TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer.
Nooshin Mirkheshti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.